Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
CLEE011X2101 : Essai de phase 1, en escalade de doses, évaluant la tolérance du LEE011, un inhibiteur de CDK4/6, chez des patients ayant une tumeur solide avancée ou un lymphome. [Informations issues du site clinicaltrials.gov et traduites par l'INCa] [essai clos aux inclusions] https://www.kusajili.fr:443/Trial/FbdeU-D-B061fo-sypkiSQ%24clee011x2101-essai-de-phase-1-en-escalade-de-doses-evaluant-la-tolerance-du-lee011-un-inhibiteur-de-cdk46-chez-des-patients-aya
I have read and accept the terms of use of the site and the Privacy Policy
Send your message